Covered recipient · General Payments record
RAMI MANOCHAKIAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$41,942.91
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,703.75 | 6 |
| Honoraria | $2,600.00 | 1 |
| Food and Beverage | $644.14 | 6 |
| Travel and Lodging | $336.96 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $4,097.76 | 6 |
| Daiichi Sankyo Inc. | $3,953.28 | 4 |
| Novocure Inc. | $2,600.00 | 1 |
| ABBVIE INC. | $2,537.50 | 1 |
| Acerta Pharma LLC | $69.38 | 1 |
| Janssen Biotech, Inc. | $26.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2,537.50 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104959957 | CMS |
| AstraZeneca Pharmaceuticals LP | $69.38 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104207885 | CMS |
| Daiichi Sankyo Inc. | $1,875.00 | 02/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089452206 | CMS |
| Daiichi Sankyo Inc. | $1,406.25 | 02/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089452208 | CMS |
| Daiichi Sankyo Inc. | $47.03 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089452210 | CMS |
| Daiichi Sankyo Inc. | $625.00 | 06/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089452204 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,340.00 | 03/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101565245 | CMS |
| E.R. Squibb & Sons, L.L.C. | $93.52 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101565430 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,920.00 | 09/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101565286 | CMS |
| E.R. Squibb & Sons, L.L.C. | $336.96 | 10/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1101565297 | CMS |
| E.R. Squibb & Sons, L.L.C. | $35.16 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101565301 | CMS |
| E.R. Squibb & Sons, L.L.C. | $372.12 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101565446 | CMS |
| Janssen Biotech, Inc. | $26.93 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078430289 | CMS |
| Novocure Inc. | $2,600.00 | 01/19/2024 | Honoraria | Undisputed | 01/23/2026 | 1119257690 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.